MedTrace Logo

Dynamic Focusing Evaluation for Prostate Cancer Treatment

NCT03632980 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2018-08-16

No results posted yet for this study

Summary

Define the best acoustic parameters for the dynamic focusing HIFU transducer in the treatment of localized Prostate Cancer.

Conditions

  • Cancer of Prostate

Interventions

DEVICE

"Ablatherm Foc/Dyn" or "Focal One" HIFU treatment

Non invasive treatment of localized prostate cancer by High Intensity Focused Ultrasound therapy, endorectal application. or Non invasive treatment of localized prostate cancer recurrency by High Intensity Focused Ultrasound therapy after radiotherapy failure, endorectal application.

Sponsors & Collaborators

  • EDAP TMS S.A.

    lead INDUSTRY

Principal Investigators

  • Albert GELET, MD · Edouard Herriot Hospital, Lyon, France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632980 on ClinicalTrials.gov